Developing novel regenerative medicine therapies to improve human health
Research within Liverpool’s Regenerative Medicine Network falls into six main categories:
The goal of this group is to develop cellular and molecular based regenerative medicine therapies that can treat patients in the early stages of kidney disease and help to prevent them from developing life threatening end stage kidney disease. Read more
The long term goal of this group is to develop more sensitive and specific methods to detect changes in chronic and acute liver disease earlier and to develop cellular and molecular-based regenerative medicine therapies (RMTs). This enables doctors to treat patients in the early stages of liver disease and prevent them from developing irreversible liver failure. Read more
The aim of this group is to develop and support regenerative and reconstructive therapies from the basic science in our laboratories to patients within the clinics in St Paul’s Eye Unit, to tackle the debilitating diseases that underlie vision loss and blindness. Read more
Researchers in this area are interested in two main areas of the Gut: The intestinal epithelium and the enteric nervous system. Researchers studying the intestinal epithelium are looking to develop both cellular and molecular therapeutics that will stimulate the rapid regeneration of the intestinal epithelium, following intestinal barrier breakdown during active inflammatory bowel disease.
Researchers studying the enteric nervous system are researching potential treatments for the life-threatening Hirschsprung's disease, a condition resulting from the congenital absence of ENS ganglion cells in the distal gut. Read more
The aim of this group is to better understand the molecular mechanisms causing tissue degeneration in the musculoskeletal system and to use stem cells and tissue engineering to reconstruct damaged tissue, alleviate pain and improve the quality of life of patients and elderly people. Read more